Vertex Pharmaceuticals Incorporated faces slowing Trikafta/Kaftrio sales and a stock-price divergence with peers. Click for this VRTX earnings update.

'Finding Her Edge,' which is based on Jennifer Iacopelli's book, follows figure skater Adriana returning to the rink, while also balancing a messy love triangle Netflix Finding Her Edge has already ...

ROME (AP) — Canada standout Jonathan David is rediscovering his form with a home World Cup approaching. David scored his third goal in four matches and Juventus beat defending champion Napoli 3-0 in ...

Just a few weeks out from the Winter Olympics and on the heels of the “Heated Rivalry” hype, Netflix’s “Finding Her Edge” gives viewers their winter sports romance fix. Retired figure skater Adriana ...

Isabella Soares is a Senior Writer for Collider, as well as a Cherry Picks-approved critic. A film and TV enthusiast from an early age, Isabella used to write reviews in her journal growing up, which ...

The overlooked middle daughter of an athletic dynasty finds herself torn between her new skating partner, a brash but talented bad boy, and her ex, now their rival in competition. By Angie Han ...

Another ice-skating romance premieres, and a reboot of “Star Search” comes to Netflix. By Shivani Gonzalez Between streaming and cable, viewers have a seemingly endless variety of things to watch.

Oppo is expected to unveil the Find N6 in February, but according to a new rumor from "a trusted industry insider" this won't be its only foldable device launching this year. Instead, it will be ...

Vertex Inc. (NASDAQ:VERX) is one of the best beaten down stocks to invest in according to analysts. On December 5, Vertex Inc. (NASDAQ:VERX) confirmed expansion of its strategic partnership with ...

With short-form video now dominant on social media, researchers are racing to understand how the highly engaging, algorithm-driven format may be reshaping the brain. From TikTok to Instagram Reels and ...

Some things will remain the same for Vertex five years from now, including its dominance in treating cystic fibrosis (CF). However, the company will likely achieve success in several new markets ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...